| Anti-CTLA-4 antibodies of IgG2a isotype enhance antitumor activity through reduction of intratumoral regulatory T cells MJ Selby, JJ Engelhardt, M Quigley, KA Henning, T Chen, M Srinivasan, ... Cancer immunology research 1 (1), 32-42, 2013 | 917 | 2013 |
| Transcriptional analysis of HIV-specific CD8+ T cells shows that PD-1 inhibits T cell function by upregulating BATF M Quigley, F Pereyra, B Nilsson, F Porichis, C Fonseca, Q Eichbaum, ... Nature medicine 16 (10), 1147-1151, 2010 | 586 | 2010 |
| VISTA is an acidic pH-selective ligand for PSGL-1 RJ Johnston, LJ Su, J Pinckney, D Critton, E Boyer, A Krishnakumar, ... Nature 574 (7779), 565-570, 2019 | 265 | 2019 |
| Preclinical development of ipilimumab and nivolumab combination immunotherapy: mouse tumor models, in vitro functional studies, and cynomolgus macaque toxicology MJ Selby, JJ Engelhardt, RJ Johnston, LS Lu, M Han, K Thudium, D Yao, ... PloS one 11 (9), e0161779, 2016 | 233 | 2016 |
| PD-1/PD-L1 interactions contribute to functional T-cell impairment in patients who relapse with cancer after allogeneic stem cell transplantation WJ Norde, F Maas, W Hobo, A Korman, M Quigley, MGD Kester, ... Cancer research 71 (15), 5111-5122, 2011 | 172 | 2011 |
| CD4 T cells are required for CD8 T cell survival during both primary and memory recall responses P Novy, M Quigley, X Huang, Y Yang The Journal of Immunology 179 (12), 8243-8251, 2007 | 172 | 2007 |
| Anti-CTLA-4 antibodies of IgG2a isotype enhance antitumor activity through reduction of intratumoral regulatory T cells. Cancer Immunol Res. 2013; 1: 32–42. doi: 10.1158/2326-6066 MJ Selby, JJ Engelhardt, M Quigley, KA Henning, T Chen, M Srinivasan, ... CIR-13-0013, 2013 | 165 | 2013 |
| Antigen availability determines CD8+ T cell-dendritic cell interaction kinetics and memory fate decisions SE Henrickson, M Perro, SM Loughhead, B Senman, S Stutte, M Quigley, ... Immunity 39 (3), 496-507, 2013 | 157 | 2013 |
| Combination of CD40 agonism and CSF-1R blockade reconditions tumor-associated macrophages and drives potent antitumor immunity KR Wiehagen, NM Girgis, DH Yamada, AA Smith, SR Chan, IS Grewal, ... Cancer immunology research 5 (12), 1109-1121, 2017 | 155 | 2017 |
| A critical role for direct TLR2-MyD88 signaling in CD8 T-cell clonal expansion and memory formation following vaccinia viral infection M Quigley, J Martinez, X Huang, Y Yang Blood, The Journal of the American Society of Hematology 113 (10), 2256-2264, 2009 | 142 | 2009 |
| A new pressure attenuation index to evaluate retinal circulation: a link to protective factors in diabetic retinopathy M Quigley, S Cohen Archives of ophthalmology 117 (1), 84-89, 1999 | 95 | 1999 |
| Antitumor activity of concurrent blockade of immune checkpoint molecules CTLA-4 and PD-1 in preclinical models. M Selby, J Engelhardt, LS Lu, M Quigley, C Wang, B Chen, AJ Korman Journal of Clinical Oncology 31 (15_suppl), 3061-3061, 2013 | 85 | 2013 |
| Pan-TAM tyrosine kinase inhibitor BMS-777607 enhances anti–PD-1 mAb efficacy in a murine model of triple-negative breast cancer C Kasikara, V Davra, D Calianese, K Geng, TE Spires, M Quigley, ... Cancer research 79 (10), 2669-2683, 2019 | 83 | 2019 |
| Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshop D Bedognetti, M Ceccarelli, L Galluzzi, R Lu, K Palucka, J Samayoa, ... Journal for immunotherapy of cancer 7, 1-23, 2019 | 78 | 2019 |
| STAT1 signaling in CD8 T cells is required for their clonal expansion and memory formation following viral infection in vivo M Quigley, X Huang, Y Yang The Journal of Immunology 180 (4), 2158-2164, 2008 | 75 | 2008 |
| Triple therapy with MerTK and PD1 inhibition plus radiotherapy promotes abscopal antitumor immune responses MS Caetano, AI Younes, HB Barsoumian, M Quigley, H Menon, C Gao, ... Clinical Cancer Research 25 (24), 7576-7584, 2019 | 50 | 2019 |
| Enhanced antitumor immunity by a novel small molecule HPK1 inhibitor D You, S Hillerman, G Locke, C Chaudhry, C Stromko, A Murtaza, Y Fan, ... Journal for ImmunoTherapy of Cancer 9 (1), 2021 | 49 | 2021 |
| Axl and Mertk receptors cooperate to promote breast cancer progression by combined oncogenic signaling and evasion of host antitumor immunity V Davra, S Kumar, K Geng, D Calianese, D Mehta, V Gadiyar, C Kasikara, ... Cancer research 81 (3), 698-712, 2021 | 48 | 2021 |
| Role of Fc–FcγR interactions in the antitumor activity of therapeutic antibodies BC Barnhart, M Quigley Immunology and cell biology 95 (4), 340-346, 2017 | 45 | 2017 |
| On-and off-responses in the photopic electroretinogram in complete-type congenital stationary night blindness M Quigley, MS Roy, M Barsoum-Homsy, L Chevrette, JL Jacob, J Milot Documenta ophthalmologica 92, 159-165, 1996 | 43 | 1996 |
